Healthcare Press

Nestlé to buy rest of stake in Aimmune Therapeutics

  • 📰 BDliveSA
  • ⏱ Reading Time:
  • 17 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 63%

Health Health Headlines News

Aimmune's Palforzia peanut allergy treatment, which recently gained US approval for children, has sales potential of $1bn

Zurich —

Nestlé said in a statement that its offer for Aimmune values the California-based biopharmaceutical firm, which it has been working with since 2016 and in which it already has a stake of 25.6%, at $2.6bn. , Behar said. The deal is expected to add to organic growth in 2021 and to cash earnings by 2022/2023.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 12. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Rest in power, King T'Challa: Fellow Marvel stars and more pay tribute to Chadwick Boseman | ChannelRest in power, King T'Challa: Fellow Marvel stars and more pay tribute to Chadwick Boseman
Source: Channel24 - 🏆 48. / 51 Read more »